Impilo invests in Decon – a leading mobility player
June 29, 2023 – Impilo has acquired a majority position in Decon Wheel AB (“Decon”), a developer and producer of high-quality power assist electrical solutions for manual wheelchairs, from its founders, who will continue as minority owners. In parallel with Impilo’s investment into Decon, Decon will acquire its long-term partner, Mobility Products, in the Netherlands.
Decon was founded in 1989 in Hyltebruk, Sweden, and employs c. 40 employees with 2022 sales of SEK 124m. Decon develops, assemblies, and distributes high-quality power-assisted electrical solutions for wheelchairs. With a user-centric development process, Decon’s solutions enable an active life for people with disabilities and thus “create freedom” in their day-to-day life. The company has its assembly facility in Hyltebruk, and from there, they serve a distributor network across +25 countries.
Decon is well positioned to continue addressing the increasing demand for power-assisted electrical solutions for wheelchairs across the European mobility segment, leveraging its high-quality product offering, customer service, and distributor network. Following the transaction, Decon management teams will remain intact, led by CEO Magnus Jakobsson.
Magnus Jakobsson, CEO and founder of Decon, comments: “We believe Impilo’s experience in the healthcare sector makes them the ideal partner to support Decon’s next growth journey, and we look forward to working closely together to remain in the forefront of power-assisted electrical solutions for wheelchairs. By partnering with Impilo, we will continue to invest and develop the company across the European markets”.
Carolina Oscarius Dahl, Partner at Impilo, comments: “As a long-term and dedicated investor in the healthcare field, we at Impilo are proud to announce this partnership with Decon. Decon provides a strong value proposition, where the company’s innovative electrical mobility solutions for wheelchairs support users with disabilities in achieving more freedom in their everyday life. We are excited about supporting the management team and Decon on the future journey”.
The parties have agreed not to disclose any transaction details. Closing is expected early Fall 2023.
Magnus Jakobsson, CEO and founder of Decon, +46 703 498 110, magnus@decon.se
Carolina Oscarius Dahl, Partner at Impilo, +46 708 633 358, csarolina.oscarius.dahl@impilo.se
Impilo was advised by Mannheimer Swartling, PwC, OPX Partners, Raison, and Marsh.
About Decon
Decon was founded in 1989 in Hyltebruk, Sweden, and has c. 40 employees with 2022 sales of SEK 124m. Decon develops, assembles and distributes high-quality power-assisted electrical solutions for wheelchairs. Products are manufactured and assembled in Hyltebruk and distributed through a large network of distributors in more than 25 countries. Learn more about Decon at www.decon.se/en/
About Impilo
Impilo is a Nordic investment company focused on long-term investments in sustainable healthcare companies active in pharmaceuticals, medical technology, healthcare services, and other health-related areas. Impilo strives to increase value of its investments through long-term active ownership. Impilo has a well-diversified portfolio of investments and has raised more c. SEK 10 billion in capital from leading Nordic and international investors since inception in 2017. The acquisition of Decon marks Impilo’s 12th investment. Learn more about Impilo at www.impilo.se/en/